-+ 0.00%
-+ 0.00%
-+ 0.00%

Burning Rock presents three lung cancer studies at WCLC 2026

PUBT·09/16/2026 03:00:28
Listen to the news
Burning Rock presents three lung cancer studies at WCLC 2026
  • Burning Rock presented three studies at the 2026 World Conference on Lung Cancer in Seoul on Sept. 15, 2026.
  • Data addressed small invasive lung adenocarcinoma biology, response prediction for neoadjuvant immunochemotherapy in lung squamous cell carcinoma.
  • Separate work evaluated pleural effusion-based molecular testing in advanced lung cancer, highlighting specimen options for precision oncology workflows.
  • Studies used the company’s OncoScreen and OncoCompass platforms to support treatment stratification and molecular testing decisions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Burning Rock Biotech Ltd. published the original content used to generate this news brief on September 16, 2026, and is solely responsible for the information contained therein.